about
Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project.Hepatitis B Seroprotection and the Response to a Challenging Dose among Vaccinated Children in Red Sea GovernorateHigh prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.Knowledge of and risky behaviours towards hepatitis B virus infection among Egyptian school children.Immune response to second vaccination series of hepatitis B virus among booster dose non-responders.Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.Association of PTPN22 1858C→T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis.Effects of obesity and some sociodemographic determinants on health-related quality of life in school-aged children in Greater CairoImmunogenicity of compulsory and booster doses of hepatitis B vaccine among children in Cairo, Egypt
P50
Q36138640-764680B0-32C1-489F-A92D-8B9B277B5D91Q37006564-0E49C8EE-F51F-479C-84EB-2CF8FA591E2DQ39421966-96F108AE-CC97-434F-8D5B-812E21669E7CQ39426733-3AC75272-2045-4AF7-B284-722029266F0DQ40115895-DF7C8EB8-6CF3-453F-A8CD-1AB6A9290FEBQ42989645-9F51E9D7-5794-4B0F-A0FF-C5B32F4C1782Q46840442-6550634B-4A43-43F1-8A78-F4EB778D78CDQ57559926-88E6D0A9-42F9-4691-BF7B-C968FB44F6ABQ91299089-83A55780-531B-4299-9D41-AB1BE717B2E5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Iman I Salama
@ast
Iman I Salama
@en
Iman I Salama
@es
Iman I Salama
@nl
type
label
Iman I Salama
@ast
Iman I Salama
@en
Iman I Salama
@es
Iman I Salama
@nl
prefLabel
Iman I Salama
@ast
Iman I Salama
@en
Iman I Salama
@es
Iman I Salama
@nl
P106
P1153
35858201800
P31
P496
0000-0001-8901-4625